Cargando…
Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling
BACKGROUND: Abnormal regulation of the inflammatory response is an important component of diseases such as diabetes, Alzheimer's disease and multiple sclerosis (MS). Lipoic acid (LA) has been shown to have antioxidant and anti-inflammatory properties and is being pursued as a therapy for these...
Autores principales: | Salinthone, Sonemany, Yadav, Vijayshree, Schillace, Robynn V., Bourdette, Dennis N., Carr, Daniel W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946928/ https://www.ncbi.nlm.nih.gov/pubmed/20927401 http://dx.doi.org/10.1371/journal.pone.0013058 |
Ejemplares similares
-
P02.183. Comparing the bioavailability of two forms of lipoic acid in multiple sclerosis
por: Salinthone, S, et al.
Publicado: (2012) -
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial
por: Spain, Rebecca, et al.
Publicado: (2017) -
Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial
por: Falardeau, Julie, et al.
Publicado: (2019) -
Lipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS
por: Bittner, Frank, et al.
Publicado: (2017) -
The Effects of cAMP-elevating Agents and Alpha Lipoic Acid on In Vitro Maturation of Mouse Germinal Vesicle Oocytes
por: Rahnama, Ali, et al.
Publicado: (2013)